Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Local therapy for rectal cancer.

Harvey G Moore1, José G Guillem

  • 1Colorectal SurgerY Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1077, New York, NY 10021, USA.

The Surgical Clinics of North America
|January 1, 2003
PubMed
Summary

Local rectal cancer treatment offers benefits like sphincter preservation but risks undertreatment due to uncertain lymph node staging. It

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Metachronous Colorectal Cancer After Segmental or Extended Resection in Patients with Lynch Syndrome.

Journal of the American College of Surgeons·2026
Same author

A history of the collaborative group of the Americas on inherited gastrointestinal cancer (CGA-IGC): 1995-2025.

Familial cancer·2026
Same author

Impact of COVID-19 on Universal Tumor Screening, Referral Rates and Attendance at Cancer Genetic Counseling at a Safety-Net University Hospital.

Current oncology (Toronto, Ont.)·2025
Same author

Disparities in Outcomes following Resection of Locally Advanced Rectal Cancer.

Current oncology (Toronto, Ont.)·2024
Same author

Watch and Wait for Near-Complete Responders-A Word of Caution.

JAMA oncology·2024
Same author

Factors Associated With Performing IPAA After Total Colectomy for Ulcerative Colitis.

Diseases of the colon and rectum·2024

Area of Science:

  • Surgical Oncology
  • Gastroenterology

Background:

  • Local procedures for distal rectal cancer provide advantages such as sphincter preservation and avoiding radical surgery.
  • Preoperative imaging and selection criteria often fail to definitively stage regional lymph node status, posing a risk for undertreatment.

Purpose of the Study:

  • To evaluate the efficacy and limitations of local therapies for distal rectal cancer.
  • To identify optimal patient selection criteria for local treatment approaches.

Main Methods:

  • Review of current data on local excision, electrocoagulation, and endocavitary radiation for rectal cancer.
  • Analysis of outcomes for T1 and T2 tumors with varying pathologic features.
  • Consideration of adjuvant therapies including chemoradiation.

Main Results:

  • Local therapy is most appropriate for carefully selected T1 tumors with favorable pathologic features.
  • T2 tumors and T1 tumors with unfavorable features show inferior local control and survival, even with chemoradiation.
  • Alternative local modalities and neoadjuvant chemoradiation followed by local excision are options for specific patient groups.

Conclusions:

  • Local excision for rectal cancer is suitable only for select T1 tumors; risks outweigh benefits for T2 or unfavorable T1 tumors.
  • Careful long-term follow-up is crucial for all patients undergoing local therapy due to significant risks of recurrence and distant failure.

Related Experiment Videos